Lumican: A new inhibitor of matrix metalloproteinase-14 activity

FEBS Letters

Volumn 588, Issue 23, 2014, Pages 4319-4324

  Pietraszek, Katarzyna ^a,b   Chatron Colliet, Aurore ^a,b   Brézillon, Stéphane ^a,b   Perreau, Corinne ^a,b   Jakubiak Augustyn, Anna ^c   Krotkiewski, Hubert ^c   Maquart, François Xavier ^a,b,d   Wegrowski, Yanusz ^a,b  

^a UFR Sciences Exactes et Naturelles   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^d REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Decorin; Lumican; MMP 14; Small leucine rich proteoglycan

Indexed keywords

COLLAGEN TYPE 1; DECORIN; LUMICAN; MATRIX METALLOPROTEINASE 14; COLLAGEN; KERATAN SULFATE; MATRIX METALLOPROTEINASE INHIBITOR; MMP14 PROTEIN, HUMAN; PROTEOCHONDROITIN SULFATE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH; ANIMAL; BINDING COMPETITION; DRUG EFFECTS; HUMAN; METABOLISM; TUMOR CELL LINE;

ANIMALS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CHONDROITIN SULFATE PROTEOGLYCANS; COLLAGEN; HUMANS; KERATAN SULFATE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITORS; MICE; PROTEOLYSIS;

EID: 84910664381     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.09.040     Document Type: Article

References (41)

1. J.M. Johnson, T.L. Young, and J.A. Rada Small leucine rich repeat proteoglycans (SLRPs) in the human sclera: identification of abundant levels of PRELP Mol. Vis. 12 2006 1057 1066
2. Z. Naito Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth J. Nippon Med. Sch. 72 2005 137 145
3. P.K. Cornuet, T.C. Blochberger, and J.R. Hassell Molecular polymorphism of lumican during corneal development Invest. Ophthalmol. Vis. Sci. 35 1994 870 877
4. Y. Matsuda, T. Yamamoto, M. Kudo, K. Kawahara, M. Kawamoto, Y. Nakajima, K. Koizumi, N. Nakazawa, T. Ishiwata, and Z. Naito Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma Int. J. Oncol. 33 2008 1177 1185
5. S. Chakravarti, R.L. Stallings, N. SundarRaj, P.K. Cornuet, and J.R. Hassell Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22 Genomics 27 1995 481 488
6. S. Kalamajski, and A. Oldberg Homologous sequence in lumican and fibromodulin leucine-rich repeat 5-7 competes for collagen binding J. Biol. Chem. 284 2009 534 539
7. C. Zeltz, S. Brezillon, C. Perreau, L. Ramont, F.X. Maquart, and Y. Wegrowski Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration FEBS Lett. 583 2009 3027 3032
8. R.V. Iozzo, and L. Schaefer Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans FEBS J. 277 2010 3864 3875
9. B. Vuillermoz, A. Khoruzhenko, M.F. D'Onofrio, L. Ramont, L. Venteo, C. Perreau, F. Antonicelli, F.X. Maquart, and Y. Wegrowski The small leucine-rich proteoglycan lumican inhibits melanoma progression Exp. Cell Res. 296 2004 294 306
10. S. Brezillon, C. Zeltz, L. Schneider, C. Terryn, B. Vuillermoz, L. Ramont, C. Perrau, M. Pluot, M.D. Diebold, A. Radwanska, M. Malicka-Blaszkiewicz, F.X. Maquart, and Y. Wegrowski Lumican inhibits B16F1 melanoma cell lung metastasis J. Physiol. Pharmacol. 60 Suppl. 4 2009 15 22
11. R.V. Iozzo The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins J. Biol. Chem. 274 1999 18843 18846
12. Y. Yamaguchi, D.M. Mann, and E. Ruoslahti Negative regulation of transforming growth factor-beta by the proteoglycan decorin Nature 346 1990 281 284
13. C. Stock, O. Jungmann, and D.G. Seidler Decorin and chondroitin-6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification J. Cell. Physiol. 226 2011 2641 2650
14. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinases J. Biol. Chem. 274 1999 21491 21494
15. H. Sato, T. Takino, and H. Miyamori Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis Cancer Sci. 96 2005 212 217
16. D.E. Kleiner, and W.G. Stetler-Stevenson Matrix metalloproteinases and metastasis Cancer Chemother. Pharmacol. 43 Suppl. 1999 S42 S51
17. M. Seiki Membrane-type matrix metalloproteinases APMIS 107 1999 137 143
18. J. Iida, K.L. Wilhelmson, M.A. Price, C.M. Wilson, D. Pei, L.T. Furcht, and J.B. McCarthy Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth J. Invest. Dermatol. 122 2004 167 176
19. H. Nagase Cell surface activation of progelatinase A (proMMP-2) and cell migration Cell Res. 8 1998 179 186
20. T. Mimura, K.Y. Han, T. Onguchi, J.H. Chang, T.I. Kim, T. Kojima, Z. Zhou, and D.T. Azar MT1-MMP-mediated cleavage of decorin in corneal angiogenesis J. Vasc. Res. 46 2009 541 550
21. Y. Li, T. Aoki, Y. Mori, M. Ahmad, H. Miyamori, T. Takino, and H. Sato Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar Cancer Res. 64 2004 7058 7064
22. E. Schonherr, L. Schaefer, B.C. O'Connell, and H. Kresse Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression J. Cell. Physiol. 187 2001 37 47
23. T. Neill, H. Painter, S. Buraschi, R.T. Owens, M.P. Lisanti, L. Schaefer, and R.V. Iozzo Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3 J. Biol. Chem. 287 2012 5492 5506
24. J. Niewiarowska, S. Brezillon, I. Sacewicz-Hofman, R. Bednarek, F.X. Maquart, M. Malinowski, M. Wiktorska, Y. Wegrowski, and C.S. Cierniewski Lumican inhibits angiogenesis by interfering with alpha2beta1 receptor activity and downregulating MMP-14 expression Thromb. Res. 128 2011 452 457
25. M. Malinowski, K. Pietraszek, C. Perreau, M. Boguslawski, V. Decot, J.F. Stoltz, L. Vallar, J. Niewiarowska, C. Cierniewski, F.X. Maquart, Y. Wegrowski, and S. Brezillon Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14 PLoS ONE 7 2012 e50709
26. S. Pahwa, M.J. Stawikowski, and G.B. Fields Monitoring and inhibiting MT1-MMP during cancer initiation and progression Cancers (Basel) 6 2014 416 435
27. C. Zeltz, S. Brezillon, J. Kapyla, J.A. Eble, H. Bobichon, C. Terryn, C. Perreau, C.M. Franz, J. Heino, F.X. Maquart, and Y. Wegrowski Lumican inhibits cell migration through alpha2beta1 integrin Exp. Cell Res. 316 2010 2922 2931
28. K.A. Piez, E.A. Eigner, and M.S. Lewis The chromatographic separation and amino acid composition of the subunits of several collagens Biochemistry 2 1963 58 66
29. K. Imai, E. Ohuchi, T. Aoki, H. Nomura, Y. Fujii, H. Sato, M. Seiki, and Y. Okada Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2 Cancer Res. 56 1996 2707 2710
30. E. Ohuchi, K. Imai, Y. Fujii, H. Sato, M. Seiki, and Y. Okada Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules J. Biol. Chem. 272 1997 2446 2451
31. D. Piecha, J. Weik, H. Kheil, G. Becher, A. Timmermann, A. Jaworski, M. Burger, and M.W. Hofmann Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants Inflamm. Res. 59 2010 379 389
32. T. Kakkar, H. Boxenbaum, and M. Mayersohn Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis Drug Metab. Dispos. 27 1999 756 762
33. M. Grossman, D. Tworowski, O. Dym, M.H. Lee, Y. Levy, G. Murphy, and I. Sagi The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function Biochemistry 49 2010 6184 6192
34. K. Pietraszek, S. Brezillon, C. Perreau, M. Malicka-Blaszkiewicz, F.X. Maquart, and Y. Wegrowski Lumican - derived peptides inhibit melanoma cell growth and migration PLoS ONE 8 2013 e76232
35. D.D. Sofeu Feugaing, M. Gotte, and M. Viola More than matrix: the multifaceted role of decorin in cancer Eur. J. Cell Biol. 92 2013 1 11
36. D. Russell, N.J. Oldham, and B.G. Davis Site-selective chemical protein glycosylation protects from autolysis and proteolytic degradation Carbohydr. Res. 344 2009 1508 1514
37. H.F. Bigg, C.J. Morrison, G.S. Butler, M.A. Bogoyevitch, Z. Wang, P.D. Soloway, and C.M. Overall Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase Cancer Res. 61 2001 3610 3618
38. K. Zarrabi, A. Dufour, J. Li, C. Kuscu, A. Pulkoski-Gross, J. Zhi, Y. Hu, N.S. Sampson, S. Zucker, and J. Cao Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration J. Biol. Chem. 286 2011 33167 33177
39. F. Sabeh, I. Ota, K. Holmbeck, H. Birkedal-Hansen, P. Soloway, M. Balbin, C. Lopez-Otin, S. Shapiro, M. Inada, S. Krane, E. Allen, D. Chung, and S.J. Weiss Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP J. Cell Biol. 167 2004 769 781
40. K.B. Hotary, E.D. Allen, P.C. Brooks, N.S. Datta, M.W. Long, and S.J. Weiss Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix Cell 114 2003 33 45
41. P. Baumann, P. Zigrino, C. Mauch, D. Breitkreutz, and R. Nischt Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes Br. J. Cancer 83 2000 1387 1393